New research led by scientists at VCU Massey Comprehensive Cancer Center suggests that a class of drugs known as MCL-1 (myeloid leukemia cell-1) inhibitors interact with a type of kinase inhibitor ...
News-Medical.Net on MSN
Repurposed drug combination shows strong promise against liver fibrosis
The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially ...
Aug. 13, 2025 12:15 PM ETAllurion Technologies Inc. (ALUR) Stock, ALUR.WS StockAI-Generated Earnings Calls Insights ...
Orserdu combined with Afinitor or Verzenio shows favorable tolerability and progression-free survival in ER-positive, HER2-negative metastatic breast cancer. Phase 2 results reveal median ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback